NFKB1 and B-cell non-Hodgkin lymphoma: Nuclear factor kappa-light-chain-enhancer of activated B cells (NFkB) activity in B cell lymphoma increases by miR-125b that targets the tumor necrosis factor alpha-induced protein 3, thereby facilitating the cancer progression and cell proliferation [27, 28].